• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.

作者信息

Rodeghiero F, Castronovo S, Dini E

出版信息

Thromb Haemost. 1982 Dec 27;48(3):339-40.

PMID:6984544
Abstract
摘要

相似文献

1
Disseminated intravascular coagulation after infusion of FEIBA (factor VIII inhibitor bypassing activity) in a patient with acquired haemophilia.
Thromb Haemost. 1982 Dec 27;48(3):339-40.
2
Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
Thromb Res. 1981;22(1-2):177-84. doi: 10.1016/0049-3848(81)90319-4.
3
The use of FEIBA (factor eight inhibitor bypassing activity) in cataract extraction in hemophilia A patient with inhibitor.
J Med. 1982;13(5-6):399-410.
4
Thrombogenicity associated with factor IX complex concentrates.与凝血因子IX复合物浓缩物相关的血栓形成性。
Semin Hematol. 1991 Jul;28(3 Suppl 6):3-5.
5
Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.凝血因子IX的血栓形成性：对凝血激活的体内影响及一例弥散性血管内凝血病例报告
Thromb Haemost. 1982 Aug 24;48(1):76-7.
6
[Clinical effects of FEIBA on hemophilia patients with inhibitors to factor VIII or IX].[活化凝血酶原复合物（FEIBA）对伴有Ⅷ或Ⅸ因子抑制物的血友病患者的临床疗效]
Nihon Ketsueki Gakkai Zasshi. 1982 Sep;45(5):987-92.
7
Effects of low-dose 'factor VIII inhibitor bypassing activity (FEIBA)' in resistant haemophilia.
Acta Haematol. 1980;64(1):12-7. doi: 10.1159/000207204.
8
[A case of sigmoid cancer who acquired factor V inhibitor producibility and treated with factor VIII inhibitor bypassing activity preparation FEIBA--with bibliographic review (author's transl)].
Rinsho Ketsueki. 1980 Nov;21(11):1664-73.
9
The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.凝血因子VIII和IX抑制物的诊断与管理：英国血友病中心医生组织指南
Br J Haematol. 2006 Jun;133(6):591-605. doi: 10.1111/j.1365-2141.2006.06087.x.
10
[Clinical use of factor IX concentrates].[凝血因子IX浓缩物的临床应用]
Schweiz Med Wochenschr. 1975 Sep 13;105(37):1188-90.

引用本文的文献

1
Myocardial infarction after FEIBA therapy in a hemophilia-B patient with a factor IX inhibitor.一名患有因子IX抑制剂的B型血友病患者在接受FEIBA治疗后发生心肌梗死。
Ann Hematol. 1992 Jun;64(6):309-11. doi: 10.1007/BF01695478.